List of Figures
Indolent Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Indolent Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Indolent Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Indolent Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Indolent Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Indolent Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Indolent Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Indolent Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Indolent Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14
Indolent Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Indolent Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Indolent Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17
Indolent Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Indolent Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Indolent Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Indolent Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Indolent Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Indolent Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Indolent Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Indolent Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Indolent Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Indolent Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 273


List of Tables
Indolent Lymphoma Therapeutics, Global, Clinical Trials by Region, 2016* 6
Indolent Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Indolent Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Indolent Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Indolent Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Indolent Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Indolent Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Indolent Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Indolent Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14
Indolent Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Indolent Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Indolent Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17
Indolent Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Indolent Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Indolent Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Indolent Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Indolent Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Indolent Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Indolent Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Indolent Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Indolent Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Indolent Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28